News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
773,503 Results
Type
Article (54215)
Company Profile (296)
Press Release (718991)
Multimedia
Podcasts (89)
Webinars (16)
Section
Business (221399)
Career Advice (2946)
Deals (37823)
Drug Delivery (119)
Drug Development (86931)
Employer Resources (185)
FDA (17292)
Job Trends (16062)
News (374341)
Policy (36193)
Tag
Academia (2918)
Academic (1)
Accelerated approval (8)
Adcomms (30)
Allergies (105)
Alliances (53682)
ALS (117)
Alzheimer's disease (1535)
Antibody-drug conjugate (ADC) (174)
Approvals (17255)
Artificial intelligence (339)
Autoimmune disease (34)
Automation (18)
Bankruptcy (393)
Best Places to Work (12236)
BIOSECURE Act (20)
Biosimilars (130)
Biotechnology (210)
Bladder cancer (99)
Brain cancer (38)
Breast cancer (378)
Cancer (2989)
Cardiovascular disease (232)
Career advice (2480)
Career pathing (33)
CAR-T (196)
CDC (38)
Cell therapy (533)
Cervical cancer (23)
Clinical research (71227)
Collaboration (1072)
Company closure (3)
Compensation (686)
Complete response letters (26)
COVID-19 (2842)
CRISPR (64)
C-suite (340)
Cystic fibrosis (114)
Data (3014)
Decentralized trials (2)
Denatured (26)
Depression (72)
Diabetes (366)
Diagnostics (6837)
Digital health (24)
Diversity (10)
Diversity, equity & inclusion (46)
Drug discovery (147)
Drug pricing (143)
Drug shortages (32)
Duchenne muscular dystrophy (129)
Earnings (93415)
Editorial (47)
Employer branding (24)
Employer resources (160)
Events (124562)
Executive appointments (903)
FDA (18966)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (972)
Gene editing (141)
Generative AI (27)
Gene therapy (411)
GLP-1 (885)
Government (5023)
Grass and pollen (6)
Guidances (181)
Healthcare (20293)
Huntington's disease (31)
IgA nephropathy (43)
Immunology and inflammation (175)
Immuno-oncology (10)
Indications (40)
Infectious disease (3026)
Inflammatory bowel disease (158)
Inflation Reduction Act (11)
Influenza (65)
Intellectual property (120)
Interviews (566)
IPO (17303)
IRA (51)
Job creations (4235)
Job search strategy (2046)
Kidney cancer (15)
Labor market (52)
Layoffs (553)
Leadership (25)
Legal (9029)
Liver cancer (85)
Lung cancer (424)
Lymphoma (211)
Machine learning (11)
Management (62)
Manufacturing (404)
MASH (95)
Medical device (14273)
Medtech (14278)
Mergers & acquisitions (21231)
Metabolic disorders (912)
Multiple sclerosis (103)
NASH (23)
Neurodegenerative disease (134)
Neuropsychiatric disorders (38)
Neuroscience (2262)
NextGen: Class of 2025 (7161)
Non-profit (4916)
Now hiring (47)
Obesity (463)
Opinion (273)
Ovarian cancer (101)
Pain (113)
Pancreatic cancer (122)
Parkinson's disease (197)
Partnered (22)
Patents (306)
Patient recruitment (163)
Peanut (55)
People (63234)
Pharmaceutical (70)
Pharmacy benefit managers (24)
Phase I (22113)
Phase II (31197)
Phase III (23365)
Pipeline (1654)
Policy (226)
Postmarket research (2990)
Preclinical (9521)
Press Release (71)
Prostate cancer (145)
Psychedelics (44)
Radiopharmaceuticals (269)
Rare diseases (500)
Real estate (6562)
Recruiting (73)
Regulatory (24775)
Reports (51)
Research institute (2571)
Resumes & cover letters (463)
Rett syndrome (10)
RNA editing (9)
RSV (54)
Schizophrenia (97)
Series A (166)
Series B (112)
Service/supplier (13)
Sickle cell disease (66)
Special edition (21)
Spinal muscular atrophy (160)
Sponsored (35)
Startups (3917)
State (2)
Stomach cancer (17)
Supply chain (80)
Tariffs (63)
The Weekly (61)
Vaccines (870)
Venture capital (55)
Weight loss (299)
Women's health (47)
Worklife (19)
Date
Today (100)
Last 7 days (332)
Last 30 days (2077)
Last 365 days (32708)
2025 (17281)
2024 (36872)
2023 (41867)
2022 (53151)
2021 (57866)
2020 (56719)
2019 (49917)
2018 (37848)
2017 (34734)
2016 (34906)
2015 (41069)
2014 (35392)
2013 (30805)
2012 (32825)
2011 (33455)
2010 (31935)
Location
Africa (943)
Alabama (64)
Alaska (7)
Arizona (260)
Arkansas (14)
Asia (43464)
Australia (7812)
California (7550)
Canada (2373)
China (704)
Colorado (327)
Connecticut (333)
Delaware (198)
Europe (96888)
Florida (1131)
Georgia (255)
Hawaii (1)
Idaho (63)
Illinois (679)
India (29)
Indiana (370)
Iowa (17)
Japan (232)
Kansas (110)
Kentucky (31)
Louisiana (15)
Maine (73)
Maryland (1057)
Massachusetts (5719)
Michigan (269)
Minnesota (472)
Mississippi (3)
Missouri (96)
Montana (32)
Nebraska (25)
Nevada (80)
New Hampshire (70)
New Jersey (2127)
New Mexico (30)
New York (2126)
North Carolina (1174)
North Dakota (10)
Northern California (3298)
Ohio (242)
Oklahoma (16)
Oregon (37)
Pennsylvania (1630)
Puerto Rico (18)
Rhode Island (38)
South America (1326)
South Carolina (35)
South Dakota (1)
Southern California (2817)
Tennessee (128)
Texas (1134)
United States (28348)
Utah (225)
Virginia (189)
Washington D.C. (77)
Washington State (651)
West Virginia (4)
Wisconsin (69)
773,503 Results for "integer holdings corporation formerly known as greatbatch inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Integer Holdings Corporation Reports First Quarter 2024 Results
Integer Holdings Corporation announced results for the three months ended March 29, 2024.
April 25, 2024
·
26 min read
Lone Star Bio
Integer to Present at 2024 Bank of America Securities Healthcare Conference on May 14
Integer Holdings Corporation today announced participation in the 2024 Bank of America Securities Healthcare Conference, to be held May 14 – 16, 2024, in Las Vegas.
May 1, 2024
·
1 min read
Deals
Integer Holdings Corporation Announces Preliminary Unaudited Sales Results and Acquisition of Pulse Technologies
Integer Holdings Corporation announced fourth quarter 2023 preliminary unaudited sales are expected to be in the range of $411 million to $413 million, an increase of 10% to 11% compared to fourth quarter 2022.
January 10, 2024
·
9 min read
Business
Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2023
Integer Holdings Corporation, a leading medical device outsource manufacturer, announced results for the three and twelve months ended December 31, 2023.
February 15, 2024
·
32 min read
Lone Star Bio
Integer to Present at 2024 Truist Securities MedTech Conference on June 18
Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced participation at the 2024 Truist Securities MedTech Conference, to be held June 17 – 18, 2024, in Boston.
June 6, 2024
·
1 min read
Business
Integer Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024
Integer Holdings Corporation announced that it plans to release financial and operational results for second quarter 2024 at 7 a.m. Central Time / 8 a.m. Eastern Time on Thursday, July 25, 2024.
June 27, 2024
·
1 min read
Business
Integer Holdings Corporation Reports Third Quarter 2023 Results
Integer Holdings Corporation, a leading medical device outsource manufacturer, announced results for the three months ended September 29, 2023.
October 26, 2023
·
28 min read
Lone Star Bio
Integer to Showcase Strategic Investments to Support Customers’ Growth and Innovation at Heart Rhythm 2024
Integer Holdings Corporation will join medtech industry leaders around the world in exhibiting at Heart Rhythm 2024, a Heart Rhythm Society educational event and exhibition in Boston from May 16 – 19, 2024.
May 7, 2024
·
2 min read
Lone Star Bio
Integer to Participate in a Virtual Fireside Chat at the KeyBanc Life Sciences & MedTech Investor Forum
Integer Holdings Corporation (NYSE:ITGR) announced today that Joe Dziedzic, President and Chief Executive Officer, will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum at 11:15 a.m. ET on Tuesday, March 19, 2024.
March 12, 2024
·
1 min read
Press Releases
Integer Technologies Launches Brand Refresh and New Website
March 12, 2025
·
2 min read
1 of 77,351
Next
